Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Dr Reddys Laboratories share price/ Dr Reddys Laboratories Profit Loss Annual
Dr Reddys Laboratories Profit & Loss Annual
Trade1,209.00 -4.90 (-0.40%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 28,011.10 | 24,669.70 | 21,545.20 | 19,047.50 |
| Total Revenue | 28,011.10 | 24,669.70 | 21,545.20 | 19,047.50 |
| Costof Revenue Total | 8,208.70 | 8,304.80 | 7,997.20 | 6,564.70 |
| Gross Profit | 19,802.40 | 16,364.90 | 13,548.00 | 12,482.80 |
| Selling/ General/ Admin Expenses Total | 11,869.00 | 8,204.80 | 7,339.90 | 6,385.10 |
| Depreciation/ Amortization | 1,470.00 | 1,250.20 | 1,165.20 | 1,228.80 |
| Unusual Expense( Income) | -152.10 | 69.90 | 930.40 | 676.80 |
| Total Operating Expense | 21,395.60 | 19,449.80 | 18,942.70 | 16,402.20 |
| Operating Income | 6,615.50 | 5,219.90 | 2,602.50 | 2,645.30 |
| Interest Inc( Exp) Net- Non- Op Total | -1,564.00 | 3,208.00 | 2,813.00 | 2,003.00 |
| Other Net | 741.90 | 628.90 | 65.70 | 42.10 |
| Net Income Before Taxes | 7,201.00 | 6,048.50 | 3,061.40 | 2,883.50 |
| Provisionfor Income Taxes | 1,623.10 | 1,541.20 | 883.30 | 963.20 |
| Net Income After Taxes | 5,577.90 | 4,507.30 | 2,178.10 | 1,920.30 |
| Net Income Before Extra Items | 5,577.90 | 4,507.30 | 2,178.10 | 1,920.30 |
| Net Income | 5,577.90 | 4,507.30 | 2,182.50 | 1,951.60 |
| Income Availableto Com Excl Extra Ord | 5,577.90 | 4,507.30 | 2,178.10 | 1,920.30 |
| Income Availableto Com Incl Extra Ord | 5,577.90 | 4,507.30 | 2,182.50 | 1,951.60 |
| Diluted Net Income | 5,577.90 | 4,507.30 | 2,182.50 | 1,951.60 |
| Diluted Weighted Average Shares | 16.67 | 16.64 | 16.63 | 16.63 |
| Diluted EPS Excluding Extra Ord Items | 334.59 | 270.89 | 130.94 | 115.46 |
| DPS- Common Stock Primary Issue | 40.00 | 40.00 | 30.00 | 25.00 |
| Diluted Normalized EPS | 327.52 | 279.44 | 165.95 | 142.73 |
| Research Development | - | 16,201.00 | 15,100.00 | 15,468.00 |
| Gain( Loss)on Saleof Assets | - | -1,211.00 | 1,119.00 | -42.00 |
| Minority Interest | - | 0.00 | 0.00 | 0.00 |
| Total Extraordinary Items | - | - | 4.40 | 31.30 |
*All figures in crores except per share values
Dr Reddys Laboratories Quick Links
Dr Reddys Laboratories Dividend Dr Reddys Laboratories Bonus Dr Reddys Laboratories News Dr Reddys Laboratories AGM Dr Reddys Laboratories Rights Dr Reddys Laboratories Splits Dr Reddys Laboratories Board Meetings Dr Reddys Laboratories Key Metrics Dr Reddys Laboratories Shareholdings Dr Reddys Laboratories Balance Sheet Dr Reddys Laboratories Cashflow Dr Reddys Laboratories Q1 Results Dr Reddys Laboratories Q2 Results Dr Reddys Laboratories Q3 Results Dr Reddys Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)